Navigation Links
Global $11.93 Billion Pharmacogenomics Market 2014-2017 & 2024 - Research and Markets
Date:4/20/2017

DUBLIN, April 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 to 2024" report to their offering.

The global pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, and is expected to reach US$ 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024.

The global pharmacogenomics market is segmented based on technology type as microarray, sequencing, polymerase chain reaction and other technologies. Sequencing dominates the market, especially with the advent of next generation sequencing attributed by high throughput screening, high accuracy and speed.

Scope of the Report

Microarray

Sequencing:
- Sanger Sequencing
- Pyrosequencing
- Next-Generation Sequencing

Polymerase Chain Reaction

Other Technologies:
- Mass Spectrometry
- Electrophoresis

The global pharmacogenomics market is further segmented in terms of therapeutic application such as oncology, cardiology, psychiatry, infectious diseases, pain management, neurological disorders and others. Among these, oncology segment dominates the therapeutic market followed by psychiatry and infectious diseases.

Currently, North America occupies the largest revenue share for global pharmacogenomics market, largely dominated by the U.S. Major growth drivers of North America market are presence of extensive and evolved healthcare infrastructure, increasing preference for better, cost effective and personalized therapeutics for various diseases and infections. Asia Pacific is expected to be the most attractive regional market and is anticipated to witness extensive growth during the forecast period.

Key Market Movements:

  • Focus on personalized medicine emphasizing on the paradigm shift in medicine from reaction to prevention. Able to design unique disease prevention strategies, prescribe more effective drugs and reduce the ADR's, enhance quality of life, increase patient compliance.
  • Recently, pharmacogenomics have being extensively used in drug development. It is used at various stages of drug development assessing and identifying effect of drug target polymorphisms on drug response.
  • Discovery of new biological mechanisms and identification of molecules with improved efficacy and safety

Market Dynamics

Market Drivers

  • Rise in investment in research and development
  • Advancement in technology pharmacogenomics engineering to create in vivo environment

Challenge

  • Lack of consistency in pharmacogenomics products

Opportunities

  • Focus on regenerative medicine
  • Increased awareness of organ transplantation

Key Topics Covered:

1. Preface

2. Executive Summary

3. Market Overview and Future Outlook

4. Global Pharmacogenomics Market, By Technology, 2014 - 2024 (US$)

5. Global Pharmacogenomics Market, By Application, 2014 - 2024 (US$)

6. Global Pharmacogenomics Market, By Geography, 2014 - 2024 (US$)

7. Company Profiles

  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • AstraZeneca plc
  • Assurex Health
  • Bayer AG
  • GeneDX
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc
  • Myriad Genetics, Inc
  • Merck & Co
  • GE Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer, Inc.
  • Pathway Genomics
  • Qiagen, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Thermo Fisher Scientific
  • Transgenomic, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/g65nsk/global

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-1193-billion-pharmacogenomics-market-2014-2017--2024---research-and-markets-300442497.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:7/31/2017)... Pharmacy, Inc. (NYSE: DPLO), has been named one of the ... Crain,s Detroit Business . The annual Crain,s Fast ... growth. This year,s edition measures growth from 2013 to 2016. ... list, visit crainsdetroit.com/awards/fast_50/2017 .  "Being named ... Phil Hagerman , CEO and chairman of Diplomat. "We,ve made ...
(Date:7/27/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... 30, 2017.  The Company reported second quarter net sales ... prior year period, and an increase of 2.1% on ... of contribution from the LDR Holding Corporation acquisition, second ... of 2016, or 0.3% on a constant currency basis. ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... ... past six years, Lightning Labels has sent out a call for users of its custom ... creativity of their designs. Submissions this year were open from May 18 to July 1 ... winners of the sixth annual Photo Contest, along with the prizes they've received:, ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Wilderness Voices”: a collection ... travel. “Wilderness Voices” is the creation of published author, Martha McKown, an ordained ... was inspired as a very young child when her older sisters studied High School ...
(Date:8/22/2017)... ... , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating to Energy NADH, a ... of modern life continually makes more demands on time and energy, people are finding ... people in vicious high/low cycles and can also cause long term health issues. More ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... I. Stevens as a 2017-2018 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting more ...
(Date:8/21/2017)... ... 2017 , ... Marathon running has surged in popularity in ... running increases exposure to ultraviolet radiation, a carcinogen that promotes skin cancer. Studies ... half may be adequately protecting themselves with proper clothing and sunscreen. , ...
Breaking Medicine News(10 mins):